Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T13201 | Target Info | |||
| Target Name | Carbonic anhydrase I (CA-I) | ||||
| Synonyms | Carbonic anhydrase B; Carbonic anhydrase 1; Carbonate dehydratase I; CAB | ||||
| Target Type | Successful Target | ||||
| Gene Name | CA1 | ||||
| Biochemical Class | Alpha-carbonic anhydrase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US2014170173 | ||||
| Title | Method of Inducing Immune Tolerance Comprising Administering Carbonic Anhydrase I. | ||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).Expert Opin Ther Pat. 2016 Aug;26(8):947-56. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.